Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomePreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Neuraxis (NRXS) Shares Outstanding (Weighted Average) (2022 - 2025)

Neuraxis (NRXS) has disclosed Shares Outstanding (Weighted Average) for 4 consecutive years, with $9.1 million as the latest value for Q4 2025.

  • Quarterly Shares Outstanding (Weighted Average) rose 31.28% to $9.1 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $9.1 million through Dec 2025, up 31.28% year-over-year, with the annual reading at $9.1 million for FY2025, 31.28% up from the prior year.
  • Shares Outstanding (Weighted Average) hit $9.1 million in Q4 2025 for Neuraxis, down from $9.9 million in the prior quarter.
  • In the past five years, Shares Outstanding (Weighted Average) ranged from a high of $9.9 million in Q3 2025 to a low of $505570.0 in Q2 2023.
  • Historically, Shares Outstanding (Weighted Average) has averaged $5.0 million across 4 years, with a median of $6.6 million in 2024.
  • Biggest five-year swings in Shares Outstanding (Weighted Average): tumbled 74.34% in 2023 and later soared 1268.95% in 2024.
  • Year by year, Shares Outstanding (Weighted Average) stood at $793655.0 in 2022, then soared by 309.79% to $3.3 million in 2023, then surged by 112.74% to $6.9 million in 2024, then skyrocketed by 31.28% to $9.1 million in 2025.
  • Business Quant data shows Shares Outstanding (Weighted Average) for NRXS at $9.1 million in Q4 2025, $9.9 million in Q3 2025, and $8.5 million in Q2 2025.